These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11360352)

  • 21. Developing a risk assessment process for current and emerging infectious diseases.
    Eglin R
    Lijec Vjesn; 2007 May; 129 Suppl 3():5. PubMed ID: 18959050
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bacterial contamination of blood preparations--new problems and new challenges].
    Vuk T
    Lijec Vjesn; 2007 May; 129 Suppl 3():15-21. PubMed ID: 18959054
    [No Abstract]   [Full Text] [Related]  

  • 23. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The BOTIA project ("Blood and Organ Transmissible Infectious Agents"): a European collection of blood samples and an observatory of agents transmitted by blood transfusion or organ transplantation].
    Lefrère JJ
    Transfus Clin Biol; 2005 Jun; 12(2):93-4. PubMed ID: 15894503
    [No Abstract]   [Full Text] [Related]  

  • 25. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 26. Global. WHO: access to safe blood is limited.
    AIDS Policy Law; 2005 Jul; 20(13):1. PubMed ID: 16041851
    [No Abstract]   [Full Text] [Related]  

  • 27. Testing, inactivation or both?
    Williams AE
    Dev Biol (Basel); 2005; 120():55-6. PubMed ID: 16050156
    [No Abstract]   [Full Text] [Related]  

  • 28. Parasitic infections in the blood supply: assessing and countering the threat.
    Wendel S; Leiby DA
    Dev Biol (Basel); 2007; 127():17-41. PubMed ID: 17486879
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-transmitted infections: existing and emerging pathogens.
    Kaur P; Basu S
    J Postgrad Med; 2005; 51(2):146-51. PubMed ID: 16006714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transfusion practice in total hip arthroplasty in Danish departments of orthopaedic surgery].
    Pedersen AB; Mehnert F; Overgaard S; Møller B; Johnsen SP
    Ugeskr Laeger; 2009 Mar; 171(12):973-7. PubMed ID: 19284915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of West Nile virus transmission by blood transfusion: a comparison of nucleic acid test screening assays.
    Gallian P; De Micco P; de Lamballerie X; Levayer T; Levacon F; Guntz P; Mercier B; Dupond I; Cornillot C; Andreu G
    Transfusion; 2005 Sep; 45(9):1540-1. PubMed ID: 16131389
    [No Abstract]   [Full Text] [Related]  

  • 35. Globalisation and blood safety.
    Farrugia A
    Blood Rev; 2009 May; 23(3):123-8. PubMed ID: 19081166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer incidence in blood transfusion recipients.
    Hjalgrim H; Edgren G; Rostgaard K; Reilly M; Tran TN; Titlestad KE; Shanwell A; Jersild C; Adami J; Wikman A; Gridley G; Wideroff L; Nyrén O; Melbye M
    J Natl Cancer Inst; 2007 Dec; 99(24):1864-74. PubMed ID: 18073377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood transfusion exposure in Denmark and Sweden.
    Kamper-Jørgensen M; Edgren G; Rostgaard K; Biggar RJ; Nyrén O; Reilly M; Titlestad K; Shanwell A; Melbye M; Hjalgrim H
    Transfusion; 2009 May; 49(5):888-94. PubMed ID: 19210324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sanitary risk and new exigencies in health protection].
    Houssin D
    Rev Prat; 2005 Nov; 55(18):1991-3. PubMed ID: 16419903
    [No Abstract]   [Full Text] [Related]  

  • 39. Danish recommendations for the transfusion of leukocyte-depleted blood components. The Danish Society of Clinical Immunology.
    Vox Sang; 1996; 70(3):185-6. PubMed ID: 8740016
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is the Danish blood transfusion service out of date?].
    Sørensen H
    Ugeskr Laeger; 1995 Jul; 157(27):3879. PubMed ID: 7645059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.